By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


SEARCH JOBS

Teva Pharmaceutical Industries Ltd. develops, produces and markets ethical drugs, generic drugs, and fine chemicals for the pharmaceutical industry and disposable products for hospitals and home care services.


YEAR FOUNDED:

1901

LEADERSHIP:

Founders: Chaim Salomon, Moshe Levin, and Yitschak Elstein

CEO: Erez Vigodman

CEO Global Operations: Carlo de Notaristefani

CEO Global Specialty Medicines: Rob Koremans

CEO Global Generic Medicines: Sigudur (Siggi) Olafsson

CFO: Eyal Desheh

CMO (Medical):

CSO (Scientific): Michael Hayden

JOBS:

Please click here for Teva Pharma job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


PRODUCTS:

All Products


Key Statistics


Email:
Ownership: Public

Web Site: Teva
Employees: 5,700
Symbol: TEVA
 



Industry
Biotechnology






Company News
Teva (TEVA) Announces Positive Top-Line Data From Second Phase III Study Of SD-809 In Tardive Dyskinesia (TD) 9/22/2016 11:18:37 AM
Bayer (BAY)’s Dermatology Unit Sale Said to Attract Teva (TEVA) and Perrigo (PRGO) 9/22/2016 6:49:26 AM
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab 9/20/2016 5:47:48 AM
Teva (TEVA) Announces Results from Exploratory 52-Week Phase 2 PRIDE-HD Study Of Pridopidine In Huntington Disease 9/19/2016 10:45:03 AM
National Business Group On Health Honors Teva (TEVA) With Best Employers For Healthy Lifestyles Award 9/15/2016 10:46:59 AM
Teva (TEVA) Strengthens Injectables Portfolio With The Launch Of An Authorized Generic Of Cubicin (Daptomycin For Injection) In The United States 9/15/2016 10:45:48 AM
Teva (TEVA) Dives Headfirst Into the Wearable Tech Market, Will Develop Huntington's Disease Device With Intel (INTC) 9/15/2016 6:42:03 AM
Teva (TEVA) To Present Latest Data In Multiple Sclerosis At 2016 ECTRIMS Congress In London 9/7/2016 12:39:33 PM
Teva (TEVA) To Present At The Wells Fargo 2016 Healthcare Conference 9/6/2016 11:20:53 AM
Mylan (MYL) Scores Again as Third Teva (TEVA) Copaxone Patent is Invalidated 9/2/2016 6:07:55 AM
12345678910...
//-->